Removed TAR Requirement for Select Cold/Cough and Acetaminophen Products

May 14, 2020

The Department of Health Care Services (DHCS) continues to closely monitor the 2019 novel Coronavirus (COVID-19) situation and provide updates and guidance to Medi-Cal providers in response to concerns or questions related to the Medi-Cal fee-for-service (FFS) and Family PACT pharmacy benefit. To that end, effectively immediately, nonlegend adult acetaminophen-containing products and nonlegend cough and cold products, selected by the department, are temporarily reinstated as covered benefits of the Medi-Cal program, without requirement of an approved Treatment Authorization Request (TAR) for fee-for-service Medi-Cal beneficiaries. The full policy document is published on the COVID-19 webpage at: Pharmacy - Coverage of Acetaminophen, and Cough and Cold Medicines for Adults. This temporary change will remain in place until further notice.

Note:
Although this policy is effective, claims will not process until system changes are complete.